寰宇娛樂文化(01046.HK)擬2341萬元收購北京物業
格隆匯1月13日丨寰宇娛樂文化(01046.HK)發佈公吿,於2021年1月13日,買方寰宇縱橫世紀電影發行(北京)有限公司(公司全資附屬公司)與賣方北京亮馬置業有限公司訂立預售合同,據此,買方已同意收購該物業,代價約為人民幣2341萬元。
該物業位於北京將台水岸家園項目8#住宅樓第一單元12層1202號,賣方將在該土地(位於北京朝陽區將台鄉駝房營村1016–34、40地塊)上興建該物業。預期該物業的總建築面積約為229.24平方米。目前該物業所在的建築物仍處於賣方興建及開發階段,預期將會落成,並須於交付日期(即2021年12月31日)前向買方交付。該物業的指定用途為住宅用途。集團將該物業用作其員工宿舍。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.